Current Advances and Future Directions of Pluripotent Stem Cells-Derived Engineered Heart Tissue for Treatment of Cardiovascular Diseases

Current Advances and Future Directions of Pluripotent Stem Cells-Derived Engineered Heart Tissue for Treatment of Cardiovascular Diseases

Cardiovascular diseases resulting from myocardial infarction (MI) remain a leading cause of death worldwide, imposing a substantial burden on global health systems. Current MI treatments, primarily pharmacological and surgical, do not regenerate lost myocardium, leaving patients at high risk for hea...

Full description

Saved in:
Bibliographic Details
Main Authors: Xingyu He, Angela Good, Wael Kalou, Waqas Ahmad, Suchandrima Dutta, Sophie Chen, Charles Noah Lin, Karthickeyan Chella Krishnan, Yanbo Fan, Wei Huang, Jialiang Liang, Yigang Wang
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Cells
Subjects:
engineered heart tissue
human pluripotent stem cells
myocardial infarction
genome editing
personalized medicine
cardiovascular therapy
Online Access:https://www.mdpi.com/2073-4409/13/24/2098
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2073-4409/13/24/2098

Similar Items